Casdin Capital Overview
Investor Type
Hedge Fund
Status
Active
Professionals
6
Investments
77
Portfolio
39
Exits
25
Casdin Capital General Information
Description
Founded in 2012, Casdin Capital is a sector-oriented hedge fund manager based in New York, New York. The firm primarily invests in companies operating in the biotechnology, healthcare, life science, information technology and industrial sectors.
Contact Information
Website
Year Founded
2012
Investor Status
Actively Seeking New Investments
Primary Investor Type
Hedge Fund
Other Investor Types
Venture Capital
Primary Office
- 1350 Avenue of the Americas
- Suite 2405
- New York, NY 10019
- United States
+1 (212) 000-0000
Casdin Capital Investments (77)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
|---|---|---|---|---|---|---|
| insitro | 26-May-2020 | Early Stage VC | 00000 | Other Healthcare Technology Systems | Startup | |
| 0000000 | 01-May-2020 | 0000 | 000.00 | Drug Discovery | Generating Revenue/Not Profitable | |
| 00000 000000000000 | 07-Apr-2020 | 00000 00000 | 0000 | Biotechnology | Generating Revenue | |
| 0000 000000000000 | 31-Mar-2020 | 00000 00000 | 0000 | Drug Discovery | Startup | |
| 00000000 | 25-Mar-2020 | 00000 00000 | 00000 | Biotechnology | Startup | |
| 000000 | 04-Mar-2020 | 00 000000000 | 0000 | Drug Discovery | Generating Revenue | |
| 00000000 | 02-Mar-2020 | 0000 | 0000 | Biotechnology | Generating Revenue | |
| 0000 000000 | 21-Feb-2020 | 00000 00000 | 0000 | Application Software | Generating Revenue | |
| Verana Health | 05-Feb-2020 | Later Stage VC | 00000 | Other Healthcare Services | Generating Revenue | |
| Vineti | 05-Feb-2020 | Later Stage VC | 0000 | Decision/Risk Analysis | Generating Revenue |
Casdin Capital Exits (24)
| Company Name | Exit Date | Exit Type | Exit Size |
|---|---|---|---|
| Oric Pharmaceuticals | 24-Apr-2020 | IPO | 00000 |
| 0000000000 0000000 | 13-Feb-2020 | 000 | 00000 |
| 00000 0000000 0000 | 29-Jan-2020 | 000 | 00000 |
| 0000000 0000000000 | 18-Jul-2019 | 000 | 0000 |
| 00000000 000000000 | 27-Jun-2019 | 000 | 00000 |
| 0000000 | 07-Feb-2019 | 000 | 00000 |
| 000000000 00000000 | 28-Sep-2018 | 000 | 00000 |
| 0000000000000 0000 | 19-Jul-2018 | 000 | 0000 |
| Neon Therapeutics | 27-Jun-2018 | IPO | 00000 |
| Magenta Therapeutics | 21-Jun-2018 | IPO | 00000 |
Casdin Capital Team (19)
| Name | Title | Deals | Funds | Boards | Office |
|---|---|---|---|---|---|
| Evans Apeadu | Chief Financial Officer | New York, NY | |||
| Lawrence Canzoneri | Chief Financial Officer | New York, NY | |||
| Alexandria Fisk | Chief Operating Officer | New York, NY | |||
| Eli Casdin | Founder, Chief Investment Officer & Managing Director | 00 | 0 | 0 | New York, NY |
| Kelly Galvin | Director, IR & Business Development | New York, NY |
6 Former Team Members
Casdin Capital Co-Investors (214)
| Name | With | Exits | Lead Partner | Series | Industry |
|---|---|---|---|---|---|
| Alexandria Venture Investments | 10 | 0 | 0 |
|
|
| GV | 00 | 0 |
|
|
|
| Third Rock Ventures | 00 | 0 | 0 |
|
|
| Foresite Capital Management | 0 | 0 |
|
|
|
| Fidelity Management & Research | 0 | 0 |
|
|